367 related articles for article (PubMed ID: 30917936)
21. Real-world study of a novel prognostic scoring system: for a more precise prognostication and better clinical treatment guidance in stages II and III colon cancer.
Liu Q; Ma Y; Luo D; Cai S; Li Q; Li X
Int J Colorectal Dis; 2018 Aug; 33(8):1107-1114. PubMed ID: 29770845
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Implications of Novel Gene Signatures in Gastric Cancer Microenvironment.
Sun M; Qiu J; Zhai H; Wang Y; Ma P; Li M; Chen B
Med Sci Monit; 2020 Aug; 26():e924604. PubMed ID: 32740646
[TBL] [Abstract][Full Text] [Related]
23. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
24. Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer.
Li X; Wen D; Li X; Yao C; Chong W; Chen H
Front Immunol; 2020; 11():1678. PubMed ID: 33013820
[TBL] [Abstract][Full Text] [Related]
25. Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomes.
Gu X; Guan J; Xu J; Zheng Q; Chen C; Yang Q; Huang C; Wang G; Zhou H; Chen Z; Zhu H
J Transl Med; 2021 Jan; 19(1):26. PubMed ID: 33407546
[TBL] [Abstract][Full Text] [Related]
26. An immune infiltration signature to predict the overall survival of patients with colon cancer.
Peng D; Wang L; Li H; Cai C; Tan Y; Xu B; Le H
IUBMB Life; 2019 Nov; 71(11):1760-1770. PubMed ID: 31301220
[TBL] [Abstract][Full Text] [Related]
27. Identifying High-Risk Stage II Colon Cancer Patients: A Three-MicroRNA-Based Score as a Prognostic Biomarker.
Caritg O; Navarro A; Moreno I; Martínez-Rodenas F; Cordeiro A; Muñoz C; Ruiz-Martinez M; Santasusagna S; Castellano JJ; Monzó M
Clin Colorectal Cancer; 2016 Dec; 15(4):e175-e182. PubMed ID: 27247088
[TBL] [Abstract][Full Text] [Related]
28. A Prognostic Model of Colon Cancer Based on the Microenvironment Component Score
Liu Y; Liu X; Xu Q; Gao X; Linghu E
In Vivo; 2022; 36(2):753-763. PubMed ID: 35241531
[TBL] [Abstract][Full Text] [Related]
29. LOXL2 Is Highly Expressed in Cancer-Associated Fibroblasts and Associates to Poor Colon Cancer Survival.
Torres S; Garcia-Palmero I; Herrera M; Bartolomé RA; Peña C; Fernandez-Aceñero MJ; Padilla G; Peláez-García A; Lopez-Lucendo M; Rodriguez-Merlo R; García de Herreros A; Bonilla F; Casal JI
Clin Cancer Res; 2015 Nov; 21(21):4892-902. PubMed ID: 26206869
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma.
Yang RH; Liang B; Li JH; Pi XB; Yu K; Xiang SJ; Gu N; Chen XD; Zhou ST
J Cell Mol Med; 2021 Dec; 25(23):10990-11001. PubMed ID: 34755462
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Analysis of Gene Expression Profiles Identifies a
Chen Z; Chen M; Xue Z; Zhu X
Cancer Biother Radiopharm; 2021 Oct; 36(8):693-704. PubMed ID: 34520234
[No Abstract] [Full Text] [Related]
32. A stable gene set for prediction of prognosis and efficacy of chemotherapy in gastric cancer.
Wu R; Guo S; Lai S; Pan G; Zhang L; Liu H
BMC Cancer; 2021 Jun; 21(1):684. PubMed ID: 34112138
[TBL] [Abstract][Full Text] [Related]
33. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
[No Abstract] [Full Text] [Related]
34. A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients.
Szkandera J; Pichler M; Absenger G; Stotz M; Weissmueller M; Samonigg H; Asslaber M; Lax S; Leitner G; Winder T; Renner W; Gerger A
Clin Cancer Res; 2014 Mar; 20(6):1687-97. PubMed ID: 24470513
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of an immune gene-set based Prognostic signature in ovarian cancer.
Shen S; Wang G; Zhang R; Zhao Y; Yu H; Wei Y; Chen F
EBioMedicine; 2019 Feb; 40():318-326. PubMed ID: 30594555
[TBL] [Abstract][Full Text] [Related]
36. Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data.
Liang L; Zeng JH; Qin XG; Chen JQ; Luo DZ; Chen G
Cell Physiol Biochem; 2018; 48(2):475-490. PubMed ID: 30016783
[TBL] [Abstract][Full Text] [Related]
37. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer.
Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y
Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067
[TBL] [Abstract][Full Text] [Related]
38. From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors.
Wei M; Xu J; Hua J; Meng Q; Liang C; Liu J; Zhang B; Wang W; Yu X; Shi S
Front Immunol; 2021; 12():654660. PubMed ID: 33968055
[TBL] [Abstract][Full Text] [Related]
39. Prognostic relevance of Src activation in stage II-III colon cancer.
Martínez-Pérez J; Lopez-Calderero I; Saez C; Benavent M; Limon ML; Gonzalez-Exposito R; Soldevilla B; Riesco-Martínez MC; Salamanca J; Carnero A; Garcia-Carbonero R
Hum Pathol; 2017 Sep; 67():119-125. PubMed ID: 28601656
[TBL] [Abstract][Full Text] [Related]
40. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value of early relapse in colon cancer.
Dai W; Feng Y; Mo S; Xiang W; Li Q; Wang R; Xu Y; Cai G
Carcinogenesis; 2018 Oct; 39(10):1235-1244. PubMed ID: 29982331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]